Altered expression of p53 and Rb tumor suppressor genes in lung cancer: Relationship with survival

International Journal of Oncology

Volumn 9, Issue 3, 1996, Pages 439-443

  Esposito, Vincenzo ^a,b   De Luca, Antonio ^b   Baldi, Alfonso ^b   D'Aponte, Antonio ^a   Cavallotti, Ivan ^a   Meoli, Ilernando ^a   Baldi, Feliciano ^a   Caputi, Mario ^a   Giordano, Antonio ^b  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

immunohistochemistry; p53; pRb; survival; tumor suppressor gene

Indexed keywords

PROTEIN P53;

ADULT; ARTICLE; CANCER SURVIVAL; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; LUNG CANCER; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROGNOSIS; TUMOR SUPPRESSOR GENE;

EID: 0029787594     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Shottenfeld D: Epidemiology of lung cancer. In: Lung Cancer: Principles and Practice. Pass HI, Mitchell JB, Johnson DH and Turrisi AT (eds). Lippincot-Raven Publishers, Philadelphia, 1996.
2. Weinberg RA: The retinoblastoma protein and cell cycle control. Cell 81: 323-330, 1995.
3. Levin WJ, Casey G, Ramos JC, Arboleda MJ, Reissmann PT and Slamon DJ: Tumor suppressor and immediate early transcription factor genes in non small cell lung cancer. Chest 106: 372-375, 1994.
4. Hu Q, Bautista C, Edwards GM, Defeo-Jones R and Harlow E: Antibodies specific for the human retinoblastoma protein identify a family of related polypeptides. Mol Cell Biol 11: 5792-5799, 1991.
5. Higashiyama M, Doi O, Kodama K, Yokouchi H and Tateishi R: Retinoblastoma protein expression in lung cancer: an immunohistochemical analysis. Oncology 51: 544-551, 1994.
6. Xu HJ, Quinlan DC, Davidson AG, Hu SX, Summers CL, Li J and Benedict WF: Altered retinoblastoma protein expression and prognosis in early stage non small cell lung carcinoma. J Natl Cancer Inst 86: 695-699, 1994.
7. Greenblatt MS, Bennett WP, Hollstein M and Harris CC: Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54: 4855-4878, 1994.
8. Navone NM, Troncoso P, Pisters LL, Goodrow TL, Palmer JL, Nihols WW, Voneschenbach AC and Conti CJ: p53 protein accumulation and gene mutation in the progression of human prostate carcinoma. J Natl Cancer Inst 85: 1657-1659, 1993.
9. Levine AJ: The tumor suppressor genes. Annu Rev Biochem 62: 623-651, 1993.
10. Passlick B, Izbicki JR, Haussinger K, Thetter O and Pantel K: Immunohistochemical detection of p53 protein is not associated with poor prognosis in non small cell lung cancer. J Thorac Cardiovasc Surg 109: 1205-1211, 1995.
11. Dosaka-Akita H, Shindoh M, Fujino M, Kinoshita I, Kenje A, Katoh M and Kawakami Y: Abnormal p53 expression in human lung cancer is associated with histologic subtypes and patient smoking history. Am J Clin Pathol 102: 660-664, 1994.
12. McLaren R, Kuzu I, Dunnill M, Harris A, Lane D and Gatter KC: The relationship of p53 immunostaining to survival in carcinoma of the lung. Br J Cancer 66: 735-738, 1992.
13. Horio Y, Takahashi T, Kuroishi T, Hibi K and Suyama M: Prognostic significance of p53 mutations and 3p deletions in primary resected non small-cell lung cancer. Cancer Res 53: 1-4, 1993.
14. Volm M and Mattern J: Immunohistochemical detection of p53 in non small cell lung cancer. J Natl Cancer Inst 86: 801-802, 1994.
15. Rodriguez NR, Rowan A, Smith MEF, Kerr IB, Bodmer WF, Gannon JV and Lane DP: p53 mutations in colorectal cancer. Proc Natl Acad Sci USA 87: 7555-7559, 1990.
16. Quinlan DC, Davidson AG, Summers CL, Warden HE and Doshi HM: Accumulation of p53 protein correlates with a poor prognosis in human lung cancer. Cancer Res 52: 4828-4831, 1992.
17. Shopland DR, Eyre HJ and Pechacek TF: Smoking attributable cancer mortality in 1991: is lung cancer now the leading cause of death among smokers in the United States? J Natl Cancer Inst 83: 1142-1148, 1991.
18. World Health Organization: Histological typing of lung tumors. 2nd edition. Geneva, pp25-26, 1981.
19. Beahrs OH, Henson DE, Hutter RVP and Kennedy BJ: Lung. Manual for Staging of Cancer. 4th edition. American Joint Committee on Cancer, Chicago pp115-122, 1992.
20. Cordon-Cardo C: Mutation of cell cycle regulators: biological and clinical implications for human neoplasia. Am J Pathol 147: 1-16, 1995.
21. Reissman PT, Koga H, Takahashy R, Figlin RA, Holmes EC, Piantadosi S, Cordon-Cardo C and Slamon DJ: Inactivation of the retinoblastoma susceptibility gene, in non small cell lung cancer. The Lung Cancer Study Group. Oncogene 8: 1913-1919, 1993.
22. Baldi A, Esposito V, De Luca A, Howard CM, Mazzarella G, Baldi F, Caputi M and Giordano A: Differential expression of the retinoblastoma gene family members in lung cancer. Clin Cancer Res 2: 1239-1245, 1996.
23. Korkolopoulou P, Oates J, Crocker J and Edwards G: p53 expression in oat and non oat small cell lung carcinomas: correlation with proliferating cell nuclear antigen. J Clin Pathol 46: 1093-1096, 1993.
24. Ebina M, Steimberg SM, Mulshine JL and Linnoila RI: Relationship of p53 overexpression and up-regulation of proliferating cell nuclear antigen with the clinical course of non small cell lung cancer. Cancer Res 54: 2496-2503, 1994.
25. Iggo R, Gatter K, Bartek J, Lane D and Harris AL: Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet 335: 675-679, 1990.
26. Esposito V, Baldi A, De Luca A, Micheli P, Mazzarella G, Baldi F, Caputi M and Giordano A: Prognostic value of p53 in non-small cell lung cancer: relationship with proliferating cell nuclear antigen and cigarette smoking. Hum Pathol (In press).